NEW YORK (GenomeWeb News) – JPT Peptide Technologies and The Institute for Medical Immunology at the Charite in Berlin announced on Wednesday an agreement to develop serological peptide biomarkers for the differential diagnosis of chronic fatigue syndrome.

Under the terms of the deal, JPT will combine its high-content peptide microarray technology with the institute's expertise in diagnosing patients with chronic fatigue syndrome in order to discover biomarkers that can be developed into diagnostic tools.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.